Large-scale analysis of HLA peptides presented by HLA-Cw4
The DOI matches its Crossref record.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This approach can yield substantial quantities of HLA-peptide complexes that can be easily purified from the medium before nUPLC-MS/MS analysis.”
From Mass spectrometry–based identification of MHC-bound peptides for immunopeptidomics (2019) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 22
- Barnea E, Beer I, Patoka R, Ziv T, Kessler O, Tzehoval E, Eisenbach L, Zavazava N, Admon A (2002) Analysis of endogenous peptides bound by soluble MHC class I molecules: a novel approach for identifying tumor-specific antigens. Eur J Immunol 32:213–222 · DOI · Paper page
- Bugawan TL, Klitz W, Blair A, Erlich HA (2000) High-resolution HLA class I typing in the CEPH families: analysis of linkage disequilibrium among HLA loci. Tiss Antigens 56:392–404 · doi:10.1034/j.1399-0039.2000.560502.x
- Buus S (1999) Description and prediction of peptide-MHC binding: the "human MHC project". Curr Opin Immunol 11:209–213 · DOI
- Cox AL, Skipper J, Chen Y, Henderson RA, Darrow TL, Shabanowitz J, Engelhard VH, Hunt DF, Slingluff CL Jr (1994) Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 264:716–719 · DOI · Paper page
- Duffy MJ, Maguire TM, Hill A, McDermott E, O'Higgins N (2000) Metalloproteinases: role in breast carcinogenesis invasion and metastasis. Breast Cancer Res 2:252–257 · DOI · Paper page
- Falk K, Rotzschke O, Grahovac B, Schendel D, Stevanovic S, Gnau V, Jung G, Strominger JL, Rammensee HG (1993) Allele-specific peptide ligand motifs of HLA-C molecules. Proc Natl Acad Sci USA 90:12005–12009 · doi:10.1073/pnas.90.24.12005
- Hunt DF, Henderson RA, Shabanowitz J, Sakaguchi K, Michel H, Sevilir N, Cox AL, Appella E, Engelhard VH (1992) Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255:1261–1263 · DOI · Paper page
- Husain I, Mohler JL, Seigler HF, Besterman JM (1994) Elevation of topoisomerase I messenger RNA protein and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy. Cancer Res 54:539–546
- de Jong A (1998) Contribution of mass spectrometry to contemporary immunology. Mass Spectrom Rev 17:311–335 · doi:10.1002/(sici)1098-2787(1998)17:5<311::aid-mas1>3.0.co;2-e
- Kuhajda FP, Pizer ES, Li JN, Mani NS, Frehywot GL, Townsend CA (2000) Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc Natl Acad Sci USA 97:3450–3454 · DOI · Paper page
- Lynch BJ, Bronstein IB, Holden JA (2001) Elevations of DNA topoisomerase I in invasive carcinoma of the breast. Breast J 7:176–180 · DOI
- MacGrogan D, Levy A, Bova GS, Isaacs WB, Bookstein R (1996) Structure and methylation-associated silencing of a gene within a homozygously deleted region of human chromosome band 8p22. Genomics 35:55–65 · DOI
- Mathijssen RH, Loos WJ, Verweij J, Sparreboom A (2002) Pharmacology of topoisomerase I inhibitors irinotecan (CPT-11) and topotecan. Curr Cancer Drug Targets 2:103–123 · doi:10.2174/1568009023333890
- Milgraum LZ, Witters LA, Pasternack GR, Kuhajda FP (1997) Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma. Clin Cancer Res 3:2115–2120
- Nishizaka S, Gomi S, Harada K, Oizumi K, Itoh K, Shichijo S (2000) A new tumor-rejection antigen recognized by cytotoxic T lymphocytes infiltrating into a lung adenocarcinoma. Cancer Res 60:4830–4837
- Oba K, Matsuyama H, Yoshihiro S, Kishi F, Takahashi M, Tsukamoto M, Kinjo M, Sagiyama K, Naito K (2001) Two putative tumor suppressor genes on chromosome arm 8p may play different roles in prostate cancer. Cancer Genet Cytogenet 124:20–26 · doi:10.1016/s0165-4608(00)00248-x
- Parker KC, Bednarek MA, Coligan JE (1994) Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 152:163–175 · DOI · Paper page
- Perrais M, Pigny P, Buisine MP, Porchet N, Aubert JP, Van Seuningen-Lempire I (2001) Aberrant expression of human mucin gene MUC5B in gastric carcinoma and cancer cells. Identification and regulation of a distal promoter. J Biol Chem 276:15386–15396 · DOI
- Prilliman K, Lindsey M, Zuo Y, Jackson KW, Zhang Y, Hildebrand W (1997) Large-scale production of class I bound peptides: assigning a signature to HLA-B*1501. Immunogenetics 45:379–385 · DOI
- Prilliman KR, Lindsey M, Jackson KW, Cole J, Bonner R, Hildebrand WH (1998) Complexity among constituents of the HLA-B*1501 peptide motif. Immunogenetics 48:89–97 · DOI
- Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S (1999) SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50:213–219 · DOI · Paper page
- Schnelzer A, Prechtel D, Knaus U, Dehne K, Gerhard M, Graeff H, Harbeck N, Schmitt M, Lengyel E (2000) Rac1 in human breast cancer: overexpression mutation analysis and characterization of a new isoform Rac1b. Oncogene 19:3013–2020 · DOI · Paper page
Cited by
Mass spectrometry–based identification of MHC-bound peptides for immunopeptidomics
Purcell, A. W., Ramarathinam, S. H., & Ternette, N. (2019) · Nature Protocols · doi:10.1038/s41596-019-0133-y · Cited by 394
Efficient peptide recovery from secreted recombinant MHC-I molecules expressed via mRNA transfection
Lazarus, D., Weinstein-Marom, H., Fishman, S., Yossef, R., Zuri, D., Barnea, E., Admon, A., Margalit, A., & Gross, G. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.03.008 · Cited by 7
Self-citation
Metadata
- Authors
- Buchsbaum, S., Barnea, E., Dassau, L., Beer, I., Milner, E., & Admon, A.
- Venue
- Immunogenetics
- Published
- 2003-06
- Volume
- 55
- Issue
- 3
- Pages
- 172-176
- ISSN
- 0093-7711
- 1432-1211
- Cited by
- 18
- References
- 0
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.